• Accueil >
  • Publications >
  • Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer inBRCA1/BRCA2mutation carriers

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer inBRCA1/BRCA2mutation carriers

1 mai 2018The Breast Journal

DOI : 10.1111/tbj.12887

Auteurs

Lucie Bignon, Jean-Pierre Fricker, Catherine Nogues, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Olivier Caron, Alain Lortholary, Laurence Faivre, Christine Lasset, Veronique Mari, Paul Gesta, Laurence Gladieff, Akila Hamimi, Thierry Petit, Michel Velten